Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring
Researchers facing "a lot uncertainty, fear and panic"
22 Jan 20255:45 PM ET By Meredith Wadman, Jocelyn Kaiser
The NIH James H. Shannon Building
Lydia Polimeni/National Institutes of Health
Donald Trump’s return to the White House is already having a big impact at the $47.4 billion U.S. National Institutes of Health (NIH), with the new administration imposing a wide range of restrictions, including the abrupt cancellation of meetings such as grant review panels. Officials have also ordered a communications pause, a freeze on hiring, and an indefinite ban on travel.
The moves have generated extensive confusion and uncertainty at the nation’s largest research agency, which has become a target for Trump’s political allies. “The impact of the collective executive orders and directives appears devastating,” one senior NIH employee says.
Today, for example, officials halted midstream a training workshop for junior scientists, called off a workshop on adolescent learning minutes before it was to begin, and canceled meetings of two advisory councils. Panels that were scheduled to review grant proposals also received eleventh-hour word that they wouldn’t be meeting.
“This kind of disruption could have long ripple effects,” says Jane Liebschutz, an opioid addiction researcher at the University of Pittsburgh who posted on Bluesky about the canceled study sections. “Even short delays will put the United States behind in research.” She and colleagues are feeling “a lot of uncertainty, fear, and panic,” Liebschutz says.
The hiring freeze is governmentwide, whereas a pause on communications and travel appears to be limited to the Department of Health and Human Services (HHS), NIH’s parent agency. Such pauses are not unprecedented when a new administration comes in. But some NIH staff suggested these measures, which include pulling job ads and rescinding offers, are more extreme than any previously.
NIH travel chief Glenda Conroy sent an email to senior agency officials early today notifying them of an “immediate and indefinite” suspension of all travel throughout HHS with few exceptions, such as currently traveling employees returning home. Researchers who planned to present their work at meetings must cancel their trips, as must NIH officials promoting agency programs off site or visiting distant branches of the agency. “Future travel requests for any reason are not authorized and should not be approved,” the memo said.
The travel ban has left many researchers, especially younger scientists, bewildered, says a senior NIH scientist who asked to remain anonymous. Today, the scientist encountered one group of early-career researchers who were scheduled to attend and present at a distant conference next week—presentations that are now impossible. “People are just at a loss because they also don’t know what’s coming next. I have never seen this level of confusion and concern in people that are extremely dedicated to their mission,” the scientist says.
Separately, HHS announced a communications ban through 1 February in a memo issued yesterday. (The Washington Post and Associated Press first reported the memo’s existence.) It orders a stop on the publishing of regulations, guidance documents, grant announcements, social media posts, press releases, and other “communications,” and the canceling of speaking engagements. Any exceptions must be applied for and approved through the president’s appointees.
“This is a short pause to allow the new team to set up a process for review and prioritization,” an NIH spokesperson says.
Another consequence of the communications pause is a freeze on meetings of federal advisory committees and study sections. NIH today canceled meetings of advisory councils at its dental and bioengineering institutes.
The council meetings include a closed-door session where grant proposals from extramural researchers that have already been approved by peer-review panels undergo a final review before the awards are made. It is not clear what will happen to those grants if the council meeting to finalize the review is canceled. Many more councils for NIH’s 24 grantmaking institutes and centers are scheduled to meet in the coming weeks.
Even more troubling to many researchers is a pause on study sections that many received word of today. Without such meetings, NIH cannot make research awards.
Previous administrations have imposed communications pauses in their first days. And the administration of Barack Obama continued a cap on attendance at scientific meetings first imposed by the George W. Bush administration, which in some cases meant staff canceled trips to meetings.
But an immediate, blanket ban on travel is unusual, says one longtime researcher in NIH's intramural program. “I don't think we've ever had this and it's pretty devastating for a postdoc or graduate student” who needs to present their work and network to move ahead in their career, the researcher says.
Another consequence of the communications pause, according to an NIH staffer involved with clinical trials at NIH's Clinical Center, is that agency staff cannot meet with patient groups or release newsletters or other information to recruit patients into trials. Another unknown is whether NIH researchers will still be allowed to submit papers to peer-reviewed journals.
Hiring is also affected. No staff vacancies can be filled; in fact, before Trump’s first day in office was over, NIH’s Office of Human Resources had rescinded existing job offers to anyone whose start date was slated for 8 February or later. It also pulled down currently posted job vacancies on USA Jobs. “Please note, these tasks had to be completed in under 90 minutes and we were unable to notify you in advance,” the 21 January email noted, asking NIH’s institutes and centers to pull down any job vacancies remaining on their own websites.
The various directives have shaken the vast community of extramural scientists NIH supports. “[We] have not seen anything concrete from NIH yet,” said one scientist at a major academic medical center. “But just like about everyone in science, we are worried and waiting.”
